RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair

BackgroundPoly(ADP-ribose)polymerase (PARP) inhibitors are a class of molecular-targeted cancer drugs. Synthetic lethality is a phenomenon that renders homologous recombination repair defective cells more sensitive to PARP inhibitors. As a component of the cohesin complex, RAD21 regulates DNA damage...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Rui Gou, Xiao Li, Hui Dong, Yuexin Hu, Ouxuan Liu, Juanjuan Liu, Bei Lin
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2022-07-01
Ráidu:	Frontiers in Oncology
Fáttát:	RAD21 ovarian cancer PARP inhibitor DNA damage repair prognosis
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fonc.2022.936550/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!